Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals

Psychological Bulletin

Volumn 137, Issue 5, 2011, Pages 717-741

  Smith, M Elizabeth ^a   Farah, Martha J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Amphetamine; Enhancement; Neuroethics; Psychopharmacology; Stimulant

Indexed keywords

AMPHETAMINE DERIVATIVE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; PRESCRIPTION DRUG;

ARTICLE; COGNITION; DRUG EFFECT; EXECUTIVE FUNCTION; HUMAN; INTELLIGENCE; LEARNING; NEUROSCIENCE; OFF LABEL DRUG USE; PSYCHOLOGICAL ASPECT; PSYCHOPHARMACOLOGY; SHORT TERM MEMORY; STATISTICS; STUDENT; UNITED STATES;

AMPHETAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; EXECUTIVE FUNCTION; HUMANS; INTELLIGENCE; LEARNING; MEMORY, SHORT-TERM; METHYLPHENIDATE; NEUROSCIENCES; OFF-LABEL USE; PRESCRIPTION DRUGS; PSYCHOPHARMACOLOGY; STUDENTS; UNITED STATES;

EID: 80052197522     PISSN: 00332909     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0023825     Document Type: Article

References (138)

1. Advokat C. What are the cognitive effects of stimulant medication? Emphasis on adults with attention-deficit/hyperactivity disorder. Neuroscience and Biobehavioral Reviews 2010, 34:1256-1266. 10.1016/j.neubiorev.2010.03.006.
2. Almeida S.S., Duntas L.H., Dye L., Nunes M.L., Prasad C., Rocha J.B.T., Guedes R.C.A. Nutrition and brain function: A multidisciplinary virtual symposium. Nutritional Neuroscience 2002, 5:311-320. 10.1080/1028415021000033776.
3. Arnsten A.F.T. Catecholamine modulation of prefrontal cortical cognitive function. Trends in Cognitive Sciences 1998, 2:436-447. 10.1016/S1364-6613(98)01240-6.
4. Arria A.M., O'Grady K.E., Caldeira K.M., Vincent K.B., Wish E.D. Nonmedical use of prescription stimulants and analgesics: Associations with social and academic behaviors among college students. Pharmacotherapy 2008, 38:1045-1060. 10.1592/phco.28.2.156.
5. Arrington M. How many Silicon Valley startup executives are hopped up on Provigil? TechCrunch http://techcrunch.com/2008/07/15/how-many-of-our-startup-executives-are-hopped-up-on-provigil/.
6. Babcock Q., Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American College Health 2000, 49:143-145. 10.1080/07448480009596296.
7. Barbaresi W.J., Katusic S.K., Colligan R.C., Weaver A.L., Jacobsen S.J. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: Does treatment with stimulant medication make a difference? Results from a population-based study. Journal of Developmental and Behavioral Pediatrics 2007, 28:274-287. 10.1097/DBP.0b013e3180cabc28.
8. Barch D.M., Carter C.S. Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers. Schizophrenia Research 2005, 77:43-58.
9. Barrett S.P., Darredeau C., Bordy L.E., Pihl R.O. Characteristics of methylphenidate misuse in a university student sample. Canadian Journal of Psychiatry/La Revue Canadienne de Psychiatrie 2005, 50:457-461.
10. Boonstra T.W., Stins J.F., Daffertshofer A., Beek P.J. Effects of sleep deprivation on neural functioning: An integrative review. Cellular & Molecular Life Sciences 2007, 64:934-946. 10.1007/s00018-007-6457-8.
11. Bostrom N., Sandberg A. Cognitive enhancement: Methods, ethics, regulatory challenges. Science and Engineering Ethics 2009, 15:311-341. 10.1007/s11948-009-9142-5.
12. Boyd C.J., McCabe S.E. Coming to terms with the nonmedical use of prescription medications. Substance Abuse Treatment, Prevention, and Policy 2008, 3:22. 10.1186/1747-597X-3-22.
13. Boyd C.J., McCabe S.E., Cranford J.A., Young A. Adolescents' motivations to abuse prescription medications. Pediatrics 2006, 118:2472-2480. 10.1542/peds.2006-1644.
14. Brandt J. The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms. Clinical Neuropsychologist 1991, 5:125-142. 10.1080/13854049108403297.
15. Breitenstein C., Flöel A., Korsukewitz C., Wailke S., Bushuven S., Knecht S. A shift of paradigm: From noradrenergic to dopaminergic modulation of learning?. Journal of the Neurological Sciences 2006, 248:42-47. 10.1016/j.jns.2006.05.012.
16. Breitenstein C., Wailke S., Bushuven S., Kamping S., Zwitserlood P., Ringelstein E.B., Knecht S. D-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. Neuropsychopharmacology 2004, 29:1704-1714. 10.1038/sj.npp.1300464.
17. Brignell C.M., Rosenthal J., Curran H.V. Pharmacological manipulations of arousal and memory for emotional material: Effects of a single dose of methylphenidate or lorazepam. Journal of Psychopharmacology 2007, 21:673-683. 10.1177/0269881107077351.
18. Brumaghim J.T., Klorman R. Methylphenidate's effects on paired-associate learning and event-related potentials of young adults. Psychophysiology 1998, 35:73-85. 10.1111/1469-8986.3510073.
19. Burns J.T., House R.F., Fensch F.C., Miller J.G. Effects of magnesium pemoline and dextroamphetamine on human learning. Science 1967, February 17, 155:849-851. 10.1126/science.155.3764.849.
20. Buschke H. Selective reminding for analysis of memory and learning. Journal of Verbal Learning & Verbal Behavior 1973, 12:543-550. 10.1016/S0022-5371(73)80034-9.
21. Buschke H., Fuld P.A. Evaluation of storage, retention, and retrieval in disordered memory and learning. Neurology 1974, 24:1019-1025.
22. Callaway E. Presidential address, 1982: The pharmacology of human information processing. Psychophysiology 1983, 20:359-370. 10.1111/j.1469-8986.1983.tb00915.x.
23. Camp-Bruno J.A., Herting R.L. Cognitive effects of milacemide and methylphenidate in healthy young adults. Psychopharmacology 1994, 115:46-52. 10.1007/BF02244750.
24. Carroll B.C., McLaughlin T.J., Blake D.R. Patterns and knowledge of nonmedical use of stimulants among college students. Archives of Pediatrics & Adolescent Medicine 2006, 160:481-485. 10.1001/archpedi.160.5.481.
25. Chamberlain S.R., Robbins T.W., Winder-Rhodes S., Muller U., Sahakian B.J., Blackwell A.D., Barnett J.H. Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biological Psychiatry 2010, 69:1192-1203. 10.1016/j.biopsych.2010.08.019.
26. Clatworthy P.L., Lewis S.J., Brichard L., Hong Y.T., Izquierdo D., Clark L., Robbins T.W. Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. Journal of Neuroscience 2009, 29:4690-4696. 10.1523/JNEUROSCI.3266-08.2009.
27. Cooper N.J., Keage H., Hermens D., Williams L.M., Debrota D., Clark C.R. The dose-dependent effect of methylphenidate on performance, cognition, and psychophysiology. Journal of Integrative Neurosciences 2005, 4:123-144. 10.1142/S0219635205000744.
28. Dean W., Morgenthaler J. Smart drugs & nutrients: How to improve your memory and increase your intelligence using the latest discoveries in neuroscience 1990, Smart Publications, Petaluma, CA.
29. DeSantis A.D., Noar S.M., Webb E.M. Nonmedical ADHD stimulant use in fraternities. Journal of Studies on Alcohol and Drugs 2009, 70:952-954.
30. DeSantis A.D., Webb E.M., Noar S.M. Illicit use of prescription ADHD medications on a college campus: A multimethodological approach. Journal of American College Health 2008, 57:315-324. 10.3200/JACH.57.3.315-324.
31. D'Esposito M., Postle B.R., Rypma B. Prefrontal cortical contributions to working memory: Evidence from event-related fMRI studies. Experimental Brain Research 2000, 133:3-11. 10.1007/s002210000395.
32. de Wit H., Crean J., Richards J.B. Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behavioral Neuroscience 2000, 114:830-837. 10.1037/0735-7044.114.4.830.
33. de Wit H., Enggasser J.L., Richards J.B. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 2002, 27:813-825. 10.1016/S0893-133X(02)00343-3.
34. Diller L. Use of growth hormone for non-growth hormone deficient children. JAMA 1996, 276:1877-1878. 10.1001/jama.276.23.1877.
35. Docherty J.R. Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA). British Journal of Pharmacology 2008, 154:606-622. 10.1038/bjp.2008.124.
36. Dockery C.A., Hueckel-Weng R., Birbaumer N., Plewnia C. Enhancement of planning ability by transcranial direct current stimulation. Journal of Neuroscience 2009, 29:7271-7277. 10.1523/JNEUROSCI.0065-09.2009.
37. Dodds C.M., Muller U., Clark L., van Loon A., Cools R., Robbins T.W. Methylphenidate has differential effects on blood oxygenation level-dependent signal related to cognitive subprocesses of reversal learning. Journal of Neuroscience 2008, 28:5976-5982. 10.1523/JNEUROSCI.1153-08.2008.
38. DuPont R.L., Coleman J.J., Bucher R.H., Wilford B.B. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. American Journal on Addictions 2008, 17:167-171. 10.1080/10550490802019642.
39. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences, USA 2001, 98:6917-6922. 10.1073/pnas.111134598.
40. Elliott R., Sahakian B.J., Matthews F., Bannerjea A., Rimmer J., Robbins T.W. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berlin) 1997, 131:196-206.
41. Farah M.J. Neuroscience and neuroethics in the 21st century. The Oxford handbook of neuroethics 2011, 761-781. Oxford University Press, Oxford, England. J. Illes, B.J. Sahakian (Eds.).
42. Farah M.J., Illes J., Cook-Deegan R., Gardner H., Kandel E., King P., Wolpe P.R. Neurocognitive enhancement: What can we do and what should we do?. Nature Reviews Neuroscience 2004, 5:421-425. 10.1038/nrn1390.
43. Fillmore M.T., Kelly T.H., Martin C.A. Effects of d-amphetamine in human models of information processing and inhibitory control. Drug and Alcohol Dependence 2005, 77:151-159. 10.1016/j.drugalcdep.2004.07.013.
44. Fitzpatrick P., Klorman R., Brumaghim J.T., Keefover R.W. Effects of methylphenidate on stimulus evaluation and response processes: Evidence from performance and event-related potentials. Psychophysiology 1988, 25:292-304. 10.1111/j.1469-8986.1988.tb01245.x.
45. Fleming K., Bigelow L.B., Weinberger D.R., Goldberg T.E. Neuropsychological effects of amphetamine may correlate with personality characteristics. Psychopharmacology Bulletin 1995, 31:357-362.
46. Flöel A., Rösser N., Michka O., Knecht S., Breitenstein C. Noninvasive brain stimulation improves language learning. Journal of Cognitive Neuroscience 2008, 20:1415-1422. 10.1162/jocn.2008.20098.
47. Friedman N.P., Miyake A., Corley R.P., Young S.E., Defries J.C., Hewitt J.K. Not all executive functions are related to intelligence. Psychological Science 2006, 17:172-179. 10.1111/j.1467-9280.2006.01681.x.
48. Froehlich T.E., Lanphear B.P., Epstein J.N., Barbaresi W.J., Katusic S.K., Kahn R.S. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Archives of Pediatrics & Adolescent Medicine 2007, 161:857-864. 10.1001/archpedi.161.9.857.
49. Gazzaniga M.S. The ethical brain 2005, Dana Press, New York, NY.
50. Giurgea C.E. Psychopharmacology tomorrow: 1984 or the little prince?. Psychological Medicine 1984, 14:491-496. 10.1017/S0033291700015075.
51. Grant D.A., Berg E.A. A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem. Journal of Experimental Psychology 1948, 38:404-411.
52. Greely H., Sahakian B., Harris J., Kessler R.C., Gazzaniga M., Campbell P., Farah M.J. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008, December 11, 456:702-705. 10.1038/456702a.
53. Haier R.J., Siegel B.V., Tang C., Abel L., Buchsbaum M.S. Intelligence and changes in regional cerebral glucose metabolic rate following learning. Intelligence 1992, 16:415-426. 10.1016/0160-2896(92)90018-M.
54. Hall K.M., Irwin M.M., Bowman K.A., Frankenberger W., Jewett D.C. Illicit use of prescribed stimulant medication among college students. Journal of American College Health 2005, 53:167-174. 10.3200/JACH.53.4.167-174.
55. Halmøy A., Fasmer O.B., Gillberg C., Haavik J. Occupational outcome in adult ADHD: Impact of symptom profile, comorbid psychiatric problems, and treatment-A cross-sectional study of 414 clinically diagnosed adult ADHD patients. Journal of Attention Disorders 2009, 13:175-187. 10.1177/1087054708329777.
56. Herman-Stahl M.A., Krebs C.P., Kroutil L.A., Heller D.C. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25. Addictive Behaviors 2007, 32:1003-1015. 10.1016/j.addbeh.2006.07.010.
57. Hillman C.H., Erickson K.I., Kramer A.F. Be smart, exercise your heart: Exercise effects on brain and cognition. Nature Reviews Neuroscience 2008, 9:58-65. 10.1038/nrn2298.
58. Hurst P.M., Radlow R., Weidner M.F. Effects of D-amphetamine on task-alternation and utility of delayed reward. American Journal of Psychology 1968, 81:391-397. 10.2307/1420636.
59. Hurst P.M., Weidner M.F., Radlow R. The effects of amphetamines upon judgments and decisions. Psychopharmacology 1967, 11:397-404. 10.1007/BF00405023.
60. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the Future national survey results on drug use, 1975-2008: Volume I. Secondary school students 2009, National Institute on Drug Abuse, Bethesda, MD, (National Institutes of Health Publication No. 09-7402).
61. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the Future national survey results on drug use, 1975-2008: Volume II. College students and adults ages 19-50 2009, National Institute on Drug Abuse, Bethesda, MD, (National Institutes of Health Publication No. 09-7403).
62. Judson R., Langdon S.W. Illicit use of prescription stimulants among college students: Prescription status, motives, theory of planned behavior, knowledge and self-diagnostic tendencies. Psychology, Health & Medicine 2009, 14:97-104. 10.1080/13548500802126723.
63. Julien R.M. A primer of drug action 2001, Holt, New York, NY.
64. Kaloyanides K.B., McCabe S.E., Cranford J.A., Teter C.J. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: Relationship with age at initiation of prescription stimulants. Pharmacotherapy 2007, 27:666-674. 10.1592/phco.27.5.666.
65. Kennedy R.S., Odenheimer R.C., Baltzley D.R., Dunlap W.P., Wood C.D. Differential effects of scopolamine and amphetamine on microcomputer-based performance tests. Aviation, Space, and Environmental Medicine 1990, 61:615-621.
66. Kirschen M.P., Davis-Ratner M.S., Jerde T.E., Schraedley-Desmond P., Desmond J.E. Enhancement of phonological memory following transcranial magnetic stimulation (TMS). Behavioural Neurology 2006, 17:187-194.
67. Klorman R., Bauer L.O., Coons H.W., Lewis J.L., Peloquin J., Perlmutter R.A., Strauss J. Enhancing effects of methylphenidate on normal young adults' cognitive processes. Psychopharmacology Bulletin 1984, 20:3-9.
68. Kroutil L.A., Van Brunt D.L., Herman-Stahl M.A., Heller D.C., Bray B.M., Penne M.A. Nonmedical use of prescription stimulants in the United States. Drug and Alcohol Dependence 2006, 84:135-143. 10.1016/j.drugalcdep.2005.12.011.
69. Kumari V., Corr P.J., Mulligan O.F., Cotter P.A., Checkley S.A., Gray J.A. Effects of acute administration of d-amphetamine and haloperidol on procedural learning in man. Psychopharmacology 1997, 129:271-276. 10.1007/s002130050190.
70. Low K.G., Gendaszek A.E. Illicit use of psychostimulants among college students: A preliminary study. Psychology, Health & Medicine 2002, 7:283-287. 10.1080/13548500220139386.
71. Lutz A., Slagter H.A., Dunne J.D., Davidson R.J. Attention regulation and monitoring in meditation. Trends in Cognitive Sciences 2008, 12:163-169. 10.1016/j.tics.2008.01.005.
72. Madrigal A. 20 percent of scientists admit using brain-enhancing drugs-do you? Wired http://www.wired.com/wiredscience/2008/04/20-of-scientist/.
73. Maher B. Poll results: Look who's doping. Nature 2008, April 9, 452:674-675. 10.1038/452674a.
74. Makris A.P., Rush C.R., Frederich R.C., Taylor A.C., Kelly T.H. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Experimental and Clinical Psychopharmacology 2007, 15:123-133. 10.1037/1064-1297.15.2.123.
75. Mattay V.S., Berman K.F., Ostrem J.L., Esposito G., Van Horn J.D., Bigelow L.B. Dextroamphetamine enhances " neural network-specific" physiological signals: A positron-emission tomography rCBF study. Journal of Neuroscience 1996, 16:4816-4822.
76. Mattay V.S., Callicott J.H., Bertolino A., Heaton I., Frank J.A., Coppola R., Weinberger D.R. Effects of dextroamphetamine on cognitive performance and cortical activation. NeuroImage 2000, 12:268-275. 10.1006/nimg.2000.0610.
77. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., Weinberger D.R. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences, USA 2003, 100:6186-6191. 10.1073/pnas.0931309100.
78. McCabe S.E., Boyd C.J. Sources of prescription drugs for illicit use. Addictive Behaviors 2005, 30:1342-1350. 10.1016/j.addbeh.2005.01.012.
79. McCabe S.E., Boyd C.J., Young A. Medical and nonmedical use of prescription drugs among secondary school students. Journal of Adolescent Health 2007, 40:76-83. 10.1016/j.jadohealth.2006.07.016.
80. McCabe S.E., Knight J.R., Teter C.J., Wechsler H. Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction 2005, 100:96-106. 10.1111/j.1360-0443.2005.00944.x.
81. McCabe S.E., Teter C.J., Boyd C.J. The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use & Misuse 2004, 39:1095-1116. 10.1081/JA-120038031.
82. McCabe S.E., Teter C.J., Boyd C.J. Medical use, illicit use, and diversion of prescription stimulant medication. Journal of Psychoactive Drugs 2006, 38:43-56. 10.3200/JACH.54.5.269-278.
83. Mehlman M.J. Cognition-enhancing drugs. Milbank Quarterly 2004, 82:483-506. 10.1111/j.0887-378X.2004.00319.x.
84. Mehta M.A., Owen A.M., Sahakian B.J., Mavaddat N., Pickard J.D., Robbins T.W. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Journal of Neuroscience 2000, 20:RC65.
85. Mintzer M.Z., Griffiths R.R. A triazolam/amphetamine dose-effect interaction study: Dissociation of effects on memory versus arousal. Psychopharmacology 2007, 192:425-440. 10.1007/s00213-007-0726-y.
86. Minzenberg M.J., Carter C.S. Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology 2008, 33:1477-1502. 10.1038/sj.npp.1301534.
87. MTA Cooperative Group 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Archives of General Psychiatry 1999, 56:1073-1086. 10.1001/archpsyc.56.12.1073.
88. Novak S.P., Kroutil L.A., Williams R.L., Van Brunt D.L. The nonmedical use of prescription ADHD medications: Results from a national Internet panel. Substance Abuse Treatment, Prevention, and Policy 2007, 2:32. 10.1186/1747-597X-2-32.
89. Oken B.S., Kishiyama S.S., Salinsky M.C. Pharmacologically induced changes in arousal: Effects on behavioral and electrophysiologic measures of alertness and attention. Electroencephalography & Clinical Neurophysiology 1995, 95:359-371. 10.1016/0013-4694(95)00124-H.
90. Owen A.M. The role of the lateral frontal cortex in mnemonic processing: The contribution of functional neuroimaging. Experimental Brain Research 2000, 133:33-43. 10.1007/s002210000398.
91. Pliszka S.R. The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biological Psychiatry 2005, 57:1385-1390. 10.1016/j.biopsych.2004.08.026.
92. Poulin C. Medical and nonmedical stimulant use among adolescents: From sanctioned to unsanctioned use. CMAJ: Canadian Medical Association Journal/Journal de l'Association Medicale Canadienne 2001, 165:1039-1044.
93. Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: Connecting the dots. Addiction 2007, 102:740-751. 10.1111/j.1360-0443.2007.01758.x.
94. Rabiner D.L., Anastopoulos A.D., Costello E.J., Hoyle R.H., McCabe S.E., Swartzwelder H.S. Motives and perceived consequences of nonmedical ADHD medication use by college students: Are students treating themselves for attention problems?. Journal of Attention Disorders 2009, 13:259-270. 10.1177/1087054708320399.
95. Rapoport J.L., Buchsbaum M.S., Weingartner H. Dextroamphetamine: Cognitive and behavioral effects in normal and hyperactive boys and normal adult males. Psychopharmacology Bulletin 1980, 16:21-23.
96. Rasmussen N. On speed: The many lives of amphetamine 2008, New York University Press, New York, NY.
97. Raven J.C. Manual for Raven's Progressive Matrices and Vocabulary Scales 1990, Oxford Psychologists Press, Oxford, England. 2nd ed.
98. Repantis D., Schlattmann P., Laisney O., Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research 2010, 62:187-206. 10.1016/j.phrs.2010.04.002.
99. Robbins T.W., Arnsten A.F. The neuropsychopharmacology of fronto-executive function: Monoaminergic modulation. Annual Review of Neuroscience 2009, 32:267-287. 10.1146/annurev.neuro.051508.135535.
100. Robbins T.W., Everett B.J. Neurobehavioral mechanisms of reward and motivation. Current Opinion in Neurobiology 1996, 6:228-236. 10.1016/S0959-4388(96)80077-8.
101. Rogers R.D., Blackshaw A.J., Middleton H.C., Matthews K., Hawtin K., Crowley C., Robbins T.W. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: Implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology 1999, 146:482-491. 10.1007/PL00005494.
102. Sahakian B., Morein-Zamir S. Professor's little helper. Nature 2007, December 20, 450:1157-1159. 10.1038/4501157a.
103. Sahakian B.J., Owen A.M. Computerized assessment in neuropsychiatry using CANTAB: Discussion paper. Journal of the Royal Society of Medicine 1992, 85:399-402.
104. Sankaranarayanan J., Puumala S.E., Kratochvil C.J. Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003. Current Medical Research and Opinion 2006, 22:1475-1491. 10.1185/030079906X112615.
105. Schlösser R.G.M., Nenadic I., Wagner G., Zysset S., Koch K., Sauer H. Dopaminergic modulation of brain systems subserving decision making under uncertainty: A study with fMRI and methylphenidate challenge. Synapse 2009, 63:429-442. 10.1002/syn.20621.
106. Schmedtje J.F., Oman C.M., Letz R., Baker E.L. Effects of scopolamine and dextroamphetamine on human performance. Aviation, Space, and Environmental Medicine 1988, 59:407-410.
107. Schroeder S.R., Mann-Koepke K., Gualtieri C.T., Eckerman D.A., Breese G.R. Methylphenidate affects strategic choice behavior in normal adult humans. Pharmacology, Biochemistry and Behavior 1987, 28:213-217. 10.1016/0091-3057(87)90217-6.
108. Servan-Schreiber D., Carter C.S., Bruno R.M., Cohen J.D. Dopamine and the mechanisms of cognition: Part II. D-amphetamine effects in human subjects performing a selective attention task. Biological Psychiatry 1998, 43:723-729. 10.1016/S0006-3223(97)00449-6.
109. Shillington A.M., Reed M.B., Lange J.E., Clapp J.D., Henry S. College undergraduate Ritalin abusers in southwestern California: Protective and risk factors. Journal of Drug Issues 2006, 36:999-1014.
110. Silber B.Y., Croft R.J., Papafotiou K., Stough C. The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology 2006, 187:154-169. 10.1007/s00213-006-0410-7.
111. Singh I., Kelleher K.J. Neuroenhancement in young people: Proposal for research, policy, and clinical management. AJOB Neuroscience 2010, 1:3-16.
112. Snodgrass J., LeBaron P. 2008 National Survey on Drug Use and Health: CAI specifications for programming English version http://www.oas.samhsa.gov/nsduh/2k8MRB/2k8Q.pdf.
113. Soetens E., Casaer S., D'Hooge R., Hueting J.E. Effect of amphetamine on long-term retention of verbal material. Psychopharmacology 1995, 119:155-162. 10.1007/BF02246156.
114. Soetens E., D'Hooge R., Hueting J.E. Amphetamine enhances human-memory consolidation. Neuroscience Letters 1993, 161:9-12. 10.1016/0304-3940(93)90127-7.
115. Sternberg S. High-speed scanning in human memory. Science 1966, August 5, 153:652-654. 10.1126/science.153.3736.652.
116. Strauss J., Lewis J.L., Klorman R., Peloquin L.J., Perlmutter R.A., Salzman L.F. Effects of methylphenidate on young adults' performance and event-related potentials in a vigilance and a paired-associates learning test. Psychophysiology 1984, 21:609-621. 10.1111/j.1469-8986.1984.tb00247.x.
117. Substance Abuse and Mental Health Services Administration Results from the 2008 National Survey on Drug Use and Health: National findings 2009, Author, Rockville, MD, (U.S. Department of Health and Human Services Publication No. SMA 09-4434). http://www.oas.samhsa.gov/nsduh/2k8nsduh/2k8Results.pdf.
118. Swanson J., Arnold L.E., Kraemer H., Hechtman L., Molina B., Hinshaw S., Wigal T. Evidence, interpretation and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of Children With ADHD (MTA): Part II. Supporting details. Journal of Attention Disorders 2008, 12:15-43. 10.1177/1087054708319525.
119. Teter C.J., McCabe S.E., Boyd C.J., Guthrie S.K. Illicit methylphenidate use in an undergraduate student sample: Prevalence and risk factors. Pharmacotherapy 2003, 23:609-617. 10.1592/phco.23.5.609.34187.
120. Teter C.J., McCabe S.E., Cranford J.A., Boyd C.J., Guthrie S.K. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. Journal of American College Health 2005, 53:253-262. 10.3200/JACH.53.6.253-262.
121. Teter C.J., McCabe S.E., LaGrange K., Cranford J.A., Boyd C.J. Illicit use of specific prescription stimulants among college students: Prevalence, motives, and routes of administration. Pharmacotherapy 2006, 26:1501-1510. 10.1592/phco.26.10.1501.
122. Thalheimer W., Cook S. How to calculate effect sizes from published research articles: A simplified methodology http://work-learning.com/effect_sizes.htm.
123. Tipper C.M., Cairo T.A., Woodward T.S., Phillips A.G., Liddle P.F., Ngan E.T. Processing efficiency of a verbal working memory system is modulated by amphetamine: An fMRI investigation. Psychopharmacology 2005, 180:634-643. 10.1007/s00213-005-0025-4.
124. Unrug A., Coenen A., van Luijtelaar G. Effects of the tranquilizer diazepam and the stimulant methylphenidate on alertness and memory. Neuropsychobiology 1997, 36:42-48. 10.1159/000119359.
125. Van Dongen H.P., Maislin G., Mullington J.M., Dinges D.F. The cumulative cost of additional wakefulness: Dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep: Journal of Sleep and Sleep Disorders Research 2003, 26:117-126.
126. Vastag B. Poised to challenge need for sleep, " wakefulness enhancer" rouses concerns. JAMA 2004, 291:167-170. 10.1001/jama.291.2.167.
127. Volkow N.D., Wang G.J., Fowler J.S., Telang F., Maynard L., Logan J., Swanson J.M. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. American Journal of Psychiatry 2004, 161:1173-1180. 10.1176/appi.ajp.161.7.1173.
128. Volkow N.D., Wang G.J., Newcorn J., Fowler J.S., Telang F., Solanto M.V., Pradhan K. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. NeuroImage 2007, 34:1182-1190. 10.1016/j.neuroimage.2006.10.014.
129. Ward A.S., Kelly T.H., Foltin R.W., Fischman M.W. Effects of d-amphetamine on task performance and social behavior of humans in a residential laboratory. Experimental and Clinical Psychopharmacology 1997, 5:130-136. 10.1037/1064-1297.5.2.130.
130. Wechsler D. Wechsler Adult Intelligence Scale-Revised 1981, Psychological Corporation, San Antonio, TX.
131. Weitzner M. Manifest anxiety, amphetamine, and performance. Journal of Psychology: Interdisciplinary and Applied 1965, 60:71-79.
132. Weyandt L.L., Janusis G., Wilson K.G., Verdi G., Paquin G., Lopes J., Dussault C. Nonmedical prescription stimulant use among a sample of college students: Relationship with psychological variables. Journal of Attention Disorders 2009, 3:284-296. 10.1177/1087054709342212.
133. White B.P., Becker-Blease K.A., Grace-Bishop K. Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. Journal of American College Health 2006, 54:261-268. 10.3200/JACH.54.5.261-268.
134. Wilens T.E. Mechanism of action of agents used in attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry 2006, 67(Suppl. 8):32-38.
135. Willett R.A. The effect of a stimulant and a depressant drug on the serial rote learning of nonsense syllables. Psychopharmacologia 1962, 3:23-34. 10.1007/BF00413103.
136. Wilson D.E., Chernov H.I., Bernard P.S., Partyka D.A., Barbaz B.S., DeStevens G. Neuropharmacological properties of Su17595A a chlorpromazine-like central nervous system depressant. Archives Internationales de Pharmacodynamie et de Therapie 1971, 191:15-23.
137. Wilson M.C., Wilman A.H., Bell E.C., Asghar S.I., Silverstone P.H. Dextroamphetamine causes a change in regional brain activity in vivo during cognitive tasks: A functional magnetic resonance imaging study of blood oxygen level-dependent response. Biological Psychiatry 2004, 56:284-291. 10.1016/j.biopsych.2004.06.008.
138. Zeeuws I., Soetens E. Verbal memory performance improved via an acute administration of D-amphetamine. Human Psychopharmacology: Clinical & Experimental 2007, 22:279-287. 10.1002/hup.848.